These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8462218)

  • 1. Vicarious excretion of technetium-99m MAG3 in a patient with polycystic renal disease.
    Wulfeck DW; Sakow NK; Senler SO
    Clin Nucl Med; 1993 Mar; 18(3):239-40. PubMed ID: 8462218
    [No Abstract]   [Full Text] [Related]  

  • 2. Tc-99m MAG3 demonstration of polycystic kidneys in tuberous sclerosis.
    Mansberg VJ; Rossleigh MA; Murray IP
    Clin Nucl Med; 1997 Aug; 22(8):555-6. PubMed ID: 9262904
    [No Abstract]   [Full Text] [Related]  

  • 3. A further application of 99Tcm-MAG3 in children.
    Chapman S; Mountford PJ; Boivin CM; Burrell DN
    Nucl Med Commun; 1992 Dec; 13(12):897-8. PubMed ID: 1334538
    [No Abstract]   [Full Text] [Related]  

  • 4. False appearance of urinary stasis on Tc-99m MAG3 renal scan secondary to vicarious tracer concentration in the gallbladder.
    Tulchinsky M; Eggli DF
    Clin Nucl Med; 1995 Sep; 20(9):836-8. PubMed ID: 8521666
    [No Abstract]   [Full Text] [Related]  

  • 5. The kidney: imaging with Tc-99m mercaptoacetyltriglycine, a technetium-labeled analog of iodohippurate.
    Russell CD; Thorstad BL; Stutzman ME; Yester MV; Fowler D; Dubovsky EV
    Radiology; 1989 Aug; 172(2):427-30. PubMed ID: 2526350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical comparison of I-131 orthoiodohippurate and the kit formulation of Tc-99m mercaptoacetyltriglycine.
    Taylor A; Ziffer JA; Steves A; Eshima D; Delaney VB; Welchel JD
    Radiology; 1989 Mar; 170(3 Pt 1):721-5. PubMed ID: 2521734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallbladder uptake simulating hydronephrosis on Tc-99m MAG3 scintigraphy.
    Rosen JM
    Clin Nucl Med; 1993 Aug; 18(8):713-4. PubMed ID: 8403709
    [No Abstract]   [Full Text] [Related]  

  • 8. Multicystic dysplastic kidney: another application of 99mTc MAG3.
    Tyrrell PN; Boivin CM; Burrell DN; Mountford PJ; Chapman S
    Clin Radiol; 1994 Jun; 49(6):400-3. PubMed ID: 8045064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of residual renal function and prediction of the prognosis of polycystic kidney disease by 99m Tc-dimercaptosuccinic acid (DMSA) renal scintigraphy.
    Kawamura J; Yoshida O
    Nihon Jinzo Gakkai Shi; 1981 Jul; 23(7):1031-4. PubMed ID: 6275152
    [No Abstract]   [Full Text] [Related]  

  • 10. Tc-99m DMSA and Tc-99m MAG3 findings in crossed renal ectopia.
    Jiménez-Heffernan A; Rebollo AC; Garcia-Martin M; Herrera C; Acosta J
    Clin Nucl Med; 1998 Apr; 23(4):255. PubMed ID: 9554207
    [No Abstract]   [Full Text] [Related]  

  • 11. Kit preparation of technetium-99m-mercaptoacetyltriglycine: analysis, biodistribution and comparison with technetium-99m-DTPA in patients with impaired renal function.
    Bannister KM; Penglis S; Bellen JC; Baker RJ; Chatterton BE
    J Nucl Med; 1990 Sep; 31(9):1568-73. PubMed ID: 2144317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of radiofrequency ablation on individual renal function: assessment by technetium-99m mercaptoacetyltriglycine renal scintigraphy.
    Mukai T; Sato S; Iguchi T; Mimura H; Yasui K; Gobara H; Saika T; Nasu Y; Kumon H; Kanazawa S
    Acta Med Okayama; 2006 Apr; 60(2):85-91. PubMed ID: 16680184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Tc-99m mercaptoacetyltriglycine in patients with impaired renal function.
    Taylor A; Eshima D; Christian PE; Milton W
    Radiology; 1987 Feb; 162(2):365-70. PubMed ID: 2948212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal clearance of technetium-99m-MAG3: normal values.
    Russell CD; Li Y; Nadiye Kahraman H; Dubovsky EV
    J Nucl Med; 1995 Apr; 36(4):706-8. PubMed ID: 7699471
    [No Abstract]   [Full Text] [Related]  

  • 15. Anomalies in hepatobiliary excretion of technetium-99m-MAG3 preparations.
    Chatterjee M; Majumder A; Iyer P; Muthukrishnan G; Das MK; Ramamoorthy N; Desai CN; Banerjee S
    Nucl Med Biol; 1996 Oct; 23(7):867-72. PubMed ID: 8971853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m MAG3 renal scintigraphy with demonstration of aortic dissection.
    Nguyen BD
    Clin Nucl Med; 2005 Aug; 30(8):586-7. PubMed ID: 16024966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile leakage accumulating in the gallbladder bed mimicking normal visualization of gallbladder in technetium-99m DISIDA hepatobiliary imaging.
    Shih WJ; Duff D; Mostowycz L
    Clin Nucl Med; 1989 Mar; 14(3):222-3. PubMed ID: 2736849
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of technetium-99m MAG3 kit with HPLC-purified technetium-99m MAG3 and OIH in rats.
    Coveney JR; Robbins MS
    J Nucl Med; 1987 Dec; 28(12):1881-7. PubMed ID: 2960790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to Obtain Perfect Positioning for Renal Flow Scintigraphy Using
    Deimer D
    J Nucl Med Technol; 2024 Jun; 52(2):102-103. PubMed ID: 37852646
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of Tc-99m DTPA and Tc-99m MAG3 perfusion time-activity curves in patients with renal allograft dysfunction.
    Aktaş A; Aras M; Colak T; Gençoğlu A; Karakayali H
    Transplant Proc; 2006 Mar; 38(2):449-53. PubMed ID: 16549144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.